
Jacquelyn Dillon
Advertisement
Articles by Jacquelyn Dillon
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Ziftomenib Plus 7+3 Yields High Response Rates in Newly Diagnosed AML
2
Pirtobrutinib Plus Venetoclax/Rituximab Improves PFS in Pretreated CLL
3
Atezolizumab/Chemo Earns FDA Priority Review in Stage III dMMR/MSI-H Colon Cancer
4
Sonrotoclax Plus Zanubrutinib Achieves >90% uMRD in Treatment-Naive CLL/SLL
5
